Meag Munich Ergo’s Eastman Chemical EMN Stock Holding History

Meag Munich Ergo’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,980	Closed	-$155K	–	300
2019 Q4	$155K	Sell	1,980 -7,867	-80%	-$605K	0.02%	468
2019 Q3	$719K	Buy	9,847 +4,735	+93%	+$340K	0.04%	425
2019 Q2	$395K	Hold	5,112	–	–	0.03%	445
2019 Q1	$388K	Buy	+5,112	New	+$406K	0.03%	449
2018 Q3	–	Sell	-56,428	Closed	-$5.67M	–	397
2018 Q2	$5.67M	Sell	56,428 -49,285	-47%	-$5.2M	0.35%	90
2018 Q1	$11M	Buy	105,713 +98,775	+1,424%	+$9.99M	0.45%	58
2017 Q4	$652K	Sell	6,938 -89,757	-93%	-$8.16M	0.03%	412
2017 Q3	$8.73M	Sell	96,695 -39,969	-29%	-$3.4M	0.36%	100
2017 Q2	$11.4M	Buy	136,664 +65,148	+91%	+$5.25M	0.5%	63
2017 Q1	$5.78M	Buy	+71,516	New	+$5.62M	0.23%	158
2015 Q4	–	Sell	-153,749	Closed	-$9.85M	–	254
2015 Q3	$9.85M	Buy	+153,749	New	+$11.4M	0.53%	66

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Meag Munich Ergo's EMN Position: Q1 2020 in Review

Meag Munich Ergo sold out of Eastman Chemical (EMN) in Q1 2020, closing a stake of 1,980 shares — an estimated $155K sold.

Meag Munich Ergo first reported a position in EMN in Q3 2015 and held it in 11 quarters. The position peaked at $11.4M in Q2 2017. 587 funds tracked by Wall St. Rank hold EMN as of Q1 2020.

Meag Munich Ergo reported no remaining Eastman Chemical position as of Q1 2020 after selling out during the quarter.
Meag Munich Ergo sold 1,980 Eastman Chemical shares in Q1 2020, an estimated $155K.
Meag Munich Ergo first reported a position in Eastman Chemical in Q3 2015 and held it in 11 quarters.
Meag Munich Ergo's Eastman Chemical position peaked at $11.4M in Q2 2017.
587 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2020.

Based on Meag Munich Ergo's 13F filing for Q1 2020, filed 23 Apr 2020.